Related Experiment Video
Updated: Jul 15, 2026
07:28
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
Comparing COPD treatment: nebulizer, metered dose inhaler, and concomitant therapy
Donald P Tashkin1, Gerald L Klein, Shoshana S Colman
1Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, Calif 90095-1690, USA. dtashkin@mednet.ucla.edu
The American Journal of Medicine
|May 1, 2007
Summary
For chronic obstructive pulmonary disease (COPD), using both a nebulizer and metered dose inhaler (MDI) significantly improved quality of life and symptoms compared to using either device alone. This combined approach offers enhanced symptom relief and convenience.
Area of Science:
- Pulmonary Medicine
- Pharmacology
- Respiratory Therapy
Background:
- Chronic obstructive pulmonary disease (COPD) management involves inhaled medications like albuterol and ipratropium.
- Delivery methods include nebulizers and metered dose inhalers (MDIs).
- Optimal delivery strategy for COPD patients remains an area of investigation.
Purpose of the Study:
- To compare the efficacy of nebulizers versus MDIs for COPD treatment.
- To evaluate the impact of concomitant nebulizer and MDI use on patient outcomes.
- To assess health-related quality of life, patient symptoms, and treatment efficacy.
Main Methods:
- Randomized controlled trial involving 140 COPD patients over 50 years old.
- Three treatment groups: nebulizer, inhaler, and concomitant nebulizer/inhaler therapy.
- Assessments included St. George's Respiratory Questionnaire, FEV1, symptom scores, and peak flow measurements at baseline and weeks 6 and 12.
Main Results:
- The concomitant treatment group showed statistically significant improvements in quality of life scores at week 6 and sustained improvement in symptom sub-scores at week 12.
- Nebulizer groups demonstrated significant improvements in questionnaire and diary symptom scores over time.
- No significant differences were observed among groups for FEV1 or peak flow measurements.
Conclusions:
- Concomitant therapy combining morning/night nebulizer use with mid-day MDI use yielded the most significant improvements in quality of life for COPD patients.
- This regimen leverages the symptom relief of nebulizers and the convenience of MDIs for on-the-go use.
- Combined therapy may offer a superior approach to managing COPD symptoms and improving patient well-being.
Related Concept Videos
01:23Inhaled Medications
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.